114 related articles for article (PubMed ID: 34637102)
1. Can Adherence to and Persistence with Inhaled Long-acting Bronchodilators Improve the Quality of Life in Patients with Chronic Obstructive Pulmonary Disease? Results from a German Disease Management Program.
Krack G; Kirsch F; Schwarzkopf L; Schramm A; Leidl R
Clin Drug Investig; 2021 Nov; 41(11):989-998. PubMed ID: 34637102
[TBL] [Abstract][Full Text] [Related]
2. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers.
Yu AP; Guérin A; Ponce de Leon D; Ramakrishnan K; Wu EQ; Mocarski M; Blum S; Setyawan J
J Med Econ; 2011; 14(4):486-96. PubMed ID: 21679019
[TBL] [Abstract][Full Text] [Related]
3. Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence.
Boland MR; van Boven JF; Kruis AL; Chavannes NH; van der Molen T; Goossens LM; Rutten-van Mölken MP
Respir Med; 2016 Jan; 110():34-45. PubMed ID: 26639189
[TBL] [Abstract][Full Text] [Related]
4. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
[TBL] [Abstract][Full Text] [Related]
5. Consistency of chronic obstructive pulmonary disease regimens for patients visiting community pharmacies with the Global Initiative for Chronic Obstructive Lung Disease recommendations.
Prosser TR; Bollmeier SG
J Am Pharm Assoc (2003); 2021; 61(3):299-307. PubMed ID: 33549503
[TBL] [Abstract][Full Text] [Related]
6. The association between adherence and dementia in chronic obstructive pulmonary disease.
Liao KM; Chen CY
Medicine (Baltimore); 2019 May; 98(20):e15646. PubMed ID: 31096487
[TBL] [Abstract][Full Text] [Related]
7. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study.
Di Martino M; Agabiti N; Bauleo L; Kirchmayer U; Cascini S; Pistelli R; Colamesta V; Patorno E; Pinnarelli L; Fusco D; Perucci CA; Davoli M;
COPD; 2014 Aug; 11(4):414-23. PubMed ID: 24090036
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study.
Wurst KE; St Laurent S; Mullerova H; Davis KJ
Int J Chron Obstruct Pulmon Dis; 2014; 9():1021-31. PubMed ID: 25285002
[TBL] [Abstract][Full Text] [Related]
9. Adherence and Persistence to Long-Acting Anticholinergics Treatment Episodes in Patients With Chronic Obstructive Pulmonary Disease.
Savaria F; Beauchesne MF; Forget A; Blais L
Ann Pharmacother; 2017 Dec; 51(12):1063-1068. PubMed ID: 28760010
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
Ágh T; Inotai A; Mészáros Á
Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
[TBL] [Abstract][Full Text] [Related]
11. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy.
Moretz C; Cole AL; Mu G; Wu B; Guisinger A; Liu Y; Hahn B; Baylis L
Int J Chron Obstruct Pulmon Dis; 2020; 15():2207-2215. PubMed ID: 32982213
[TBL] [Abstract][Full Text] [Related]
13. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
[TBL] [Abstract][Full Text] [Related]
14. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients.
Dhamane AD; Schwab P; Hopson S; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():115-122. PubMed ID: 28053521
[TBL] [Abstract][Full Text] [Related]
15. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
16. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
[TBL] [Abstract][Full Text] [Related]
17. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
[TBL] [Abstract][Full Text] [Related]
18. Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
Mueller S; Wilke T; Bechtel B; Punekar YS; Mitzner K; Virchow JC
Respir Med; 2017 Jan; 122():1-11. PubMed ID: 27993284
[TBL] [Abstract][Full Text] [Related]
19. Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA.
Stanford RH; Parker ED; Reinsch TK; Buikema AR; Blauer-Peterson C
Respir Med; 2019 Apr; 150():1-7. PubMed ID: 30961933
[TBL] [Abstract][Full Text] [Related]
20. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
